MX2023014468A - Vacuna contra el coronavirus a base de particulas similares al virus. - Google Patents
Vacuna contra el coronavirus a base de particulas similares al virus.Info
- Publication number
- MX2023014468A MX2023014468A MX2023014468A MX2023014468A MX2023014468A MX 2023014468 A MX2023014468 A MX 2023014468A MX 2023014468 A MX2023014468 A MX 2023014468A MX 2023014468 A MX2023014468 A MX 2023014468A MX 2023014468 A MX2023014468 A MX 2023014468A
- Authority
- MX
- Mexico
- Prior art keywords
- coronavirus
- virus
- cov
- particle vaccine
- sars
- Prior art date
Links
- 241000711573 Coronaviridae Species 0.000 title 1
- 108010042365 Virus-Like Particle Vaccines Proteins 0.000 title 1
- 241001678559 COVID-19 virus Species 0.000 abstract 3
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 230000008685 targeting Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163197952P | 2021-06-07 | 2021-06-07 | |
| PCT/US2022/032201 WO2022260960A1 (en) | 2021-06-07 | 2022-06-03 | Virus-like particle vaccine for coronavirus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023014468A true MX2023014468A (es) | 2024-01-17 |
Family
ID=84425412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023014468A MX2023014468A (es) | 2021-06-07 | 2022-06-03 | Vacuna contra el coronavirus a base de particulas similares al virus. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240252621A1 (https=) |
| EP (1) | EP4351638A4 (https=) |
| JP (1) | JP2024520730A (https=) |
| KR (1) | KR20240019213A (https=) |
| CN (1) | CN118159288A (https=) |
| AU (1) | AU2022289462A1 (https=) |
| CA (1) | CA3221041A1 (https=) |
| IL (1) | IL308842A (https=) |
| MX (1) | MX2023014468A (https=) |
| WO (1) | WO2022260960A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4709741A1 (en) * | 2023-05-12 | 2026-03-18 | Icosavax, Inc. | Coronavirus spike glycoprotein receptor binding domains and uses thereof |
| CN121758566A (zh) * | 2023-11-03 | 2026-03-31 | 广东蓝玉生物科技有限公司 | 非洲猪瘟病毒e248r蛋白的免疫原性组合物及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9585953B2 (en) * | 2011-03-22 | 2017-03-07 | Mucosis B.V. | Immunogenic compositions in particulate form and methods for producing the same |
| CN112521511B (zh) * | 2020-12-07 | 2023-03-14 | 中山大学 | 一种含EB病毒gB蛋白的自组装纳米颗粒及其制备方法与应用 |
-
2022
- 2022-06-03 MX MX2023014468A patent/MX2023014468A/es unknown
- 2022-06-03 IL IL308842A patent/IL308842A/en unknown
- 2022-06-03 EP EP22820815.3A patent/EP4351638A4/en active Pending
- 2022-06-03 KR KR1020247000038A patent/KR20240019213A/ko active Pending
- 2022-06-03 AU AU2022289462A patent/AU2022289462A1/en active Pending
- 2022-06-03 CA CA3221041A patent/CA3221041A1/en active Pending
- 2022-06-03 JP JP2023574797A patent/JP2024520730A/ja active Pending
- 2022-06-03 CN CN202280055149.2A patent/CN118159288A/zh active Pending
- 2022-06-03 US US18/565,728 patent/US20240252621A1/en active Pending
- 2022-06-03 WO PCT/US2022/032201 patent/WO2022260960A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20240252621A1 (en) | 2024-08-01 |
| JP2024520730A (ja) | 2024-05-24 |
| CA3221041A1 (en) | 2022-12-15 |
| CN118159288A (zh) | 2024-06-07 |
| AU2022289462A1 (en) | 2023-12-14 |
| IL308842A (en) | 2024-01-01 |
| WO2022260960A1 (en) | 2022-12-15 |
| EP4351638A4 (en) | 2025-05-14 |
| KR20240019213A (ko) | 2024-02-14 |
| AU2022289462A9 (en) | 2024-01-04 |
| EP4351638A1 (en) | 2024-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2022155530A8 (en) | Variant strain-based coronavirus vaccines | |
| MX2021006342A (es) | Mutantes de virus de influenza y usos para los mismos. | |
| WO2010019262A3 (en) | Polyvalent vaccine | |
| MX2021000285A (es) | Composiciones que comprenden cepas bacterianas. | |
| MX346245B (es) | Proteina de fusion que comprende el mutante crm197 no toxico de toxina de difteria. | |
| MX2018015506A (es) | Vacuna contra virus de bronquitis infecciosa. | |
| MX2023006203A (es) | Vacunas novedosas contra el virus de zika. | |
| BR112013011194A2 (pt) | partículas de glicoproteína semelhantes a vírus (vlps) da raiva. | |
| EP3725328A3 (en) | Novel adjuvant compositions | |
| MX2023014468A (es) | Vacuna contra el coronavirus a base de particulas similares al virus. | |
| WO2007024941A3 (en) | Polyvalent vaccine | |
| BR112016007919A2 (pt) | vacinas atenuadas vivas | |
| BRPI1007721B1 (pt) | composição de vacina para uso na indução de uma resposta imunológica contra um rotavírus em um indivíduo, cepa de rotavírus isolado de cdc-9 e cepa de rotavírus isolado de cdc-66 | |
| WO2019090233A3 (en) | Method for inactivating zika virus and for determining the completeness of inactivation | |
| BR112012019637A2 (pt) | método de indução de anticorpos neutralizantes contra quatro sorotipos da febre da dengue, vírus da caxumba, vírus do sarampo e rubéola em um mamífero, kit de imunização e uso de vírus vacinais tetravalentes da dengue e trivalentes de mmr para a fabricação de uma vacina para a imunização | |
| NZ715459A (en) | A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same | |
| MY189495A (en) | Hand, foot, and mouth vaccines and methods of manufacture and use thereof | |
| AU2017261305A8 (en) | DNA monoclonal antibodies targeting influenza virus | |
| WO2022204713A3 (en) | Antibodies to sars-cov-2 | |
| MX2024003337A (es) | Composiciones inmunogenicas contra la influenza. | |
| WO2022261297A3 (en) | Broadly reactive viral antigens as immunogens, compositions and methods of use thereof | |
| WO2023067193A3 (en) | Compositions for administration of different doses of rna | |
| MX2023011129A (es) | Mutantes del virus de la influenza b y usos de los mismos. | |
| WO2019075300A3 (en) | Mayaro virus consensus antigens, dna antibody constructs for use against mayaro virus, and combinations thereof | |
| WO2019139648A3 (en) | Dna antibody constructs for use against ebola virus |